CHICO, Calif.--(BUSINESS WIRE)--PinPointe USA, Inc. a leader in light-based infection therapy announced today Health Canada clearance and the commercial launch of the PinPointe FootLaser in Canada. This patented technology, available worldwide, is the first and only device to receive FDA clearance in the US, indicated for use for the temporary increase of clear nail in patients with onychomycosis (nail fungus).
